Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercepharma.com
FiercePharma
Get the latest updates from FiercePharma directly as they happen.
Follow now 384 followers
Latest posts
Last updated about 14 hours ago
SK Life Science Xcopri ad meets a roadblock with FDA untitled letter
about 14 hours ago
A few months after SK Life Science began rolling out a road...
Novo shares tumble after 2 trial misses for semaglutide in Alzheimer's disease
about 14 hours ago
Novo Nordisk has come up short in two phase 3 trials of...
Merck's partner Kelun touts phase 3 win for ADC-Keytruda combo in first-line lung cancer
about 15 hours ago
A combination of Merck-partnered sac-TMT and Keytruda led to a “statistically significant...
In letter to Makary, biotech CEOs push for FDA stability and say volatility threatens US innovation
about 16 hours ago
Hundreds of industry leaders have signed a letter to FDA Director Marty...
In Q3, drugmakers saw a marked decline in US vaccine sales as Eli Lilly kicked into higher gear
about 23 hours ago
The commercial effects of an emboldened anti-vaccine movement in the U.S. were...
Lilly levels up Alzheimer’s awareness with Chris Hemsworth collab, major media buys
1 day ago
Eli Lilly's latest high-profile crossovers—which include a starry TV partnership and the...
AstraZeneca boosts its presence in Maryland with $2B manufacturing investment
3 days ago
Maryland is becoming the home away from home for British drugmaker AstraZeneca...
FDA grants game-changing perioperative approval to Padcev, Keytruda combo in bladder cancer
4 days ago
The approval came "months earlier than anticipated," Pfizer's Chief Oncology Officer, Jeff...
Texas files suit against Sanofi, BMS over ‘deceptive’ Plavix marketing
4 days ago
Texas Attorney General Ken Paxton filed a lawsuit Thursday on behalf of...
FDA launches investigation into Takeda's Adzynma following reported pediatric death
4 days ago
The FDA has opened an investigation into Takeda’s recombinant protein med Adzynma...
Australian government rejects Cosette's proposed Mayne Pharma buyout, citing 'national interest'
4 days ago
Cosette had been attempting to invalidate its $430 million buyout of Australia's...
GSK's Tesaro, AnaptysBio lock horns in court over Jemperli agreement
4 days ago
Some four years into Jemperli’s commercial lifespan, a rift has emerged between...